Donald Tsai
Physician · COBIUS HEALTHCARE SOLUTIONS
Credentials: · · ·
History
- Present
COBIUS HEALTHCARE SOLUTIONS
- 1997–2000
1994–1997
1990–1994
Research
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
The Lancet · 2021 · 391 citations
Transplantation · 2001 · First of 10 authors · Corresponding · 279 citations
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors
New England Journal of Medicine · 2022 · 232 citations

48 papers

39 papers

30 papers

26 papers

25 papers · 4 as a fellow

16 papers

13 papers

12 papers
Clinical trials
- 2010–2013
Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia
Principal investigator · Terminated · Phase 2
Abramson Cancer Center at Penn Medicine
- 2004
Study of Bexarotene in Patients With Acute Myeloid Leukemia
Principal investigator · Completed · Phase 1
Abramson Cancer Center at Penn Medicine
- 2019–2025
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
Study director · Completed · Phase 1, Phase 2
Loxo Oncology, Inc.



